Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identification of transcripts modulated by ETV6 expression.

Gino Boily1, Josiane Larose, Sylvie Langlois

  • 1Division of Hematology-oncology, Research Centre, Sainte-Justine Hospital, Montreal, QC, Canada.

British Journal of Haematology
|October 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic Leukemia.

Clinical pharmacology and therapeutics·2026
Same author

Acceptability and functional benefits of a health promotion program in pediatric oncology: a mixed-methods study.

Frontiers in pediatrics·2026
Same author

Endothelin-1 overexpression in mice increases vascular Vegfa164 and Vegfa188 alternative splice isoforms via enhanced Khdrbs3 expression.

Journal of hypertension·2026
Same author

Cell-Free DNA Uncovered Tumor Heterogeneity and Informed Targeted Therapy in a Pediatric Rhabdomyosarcoma.

JCO precision oncology·2026
Same author

Clinical outcomes after nondiagnostic prenatal exome sequencing: Need for balancing reassurance and residual risks in genetic counseling.

Journal of genetic counseling·2026
Same author

Validation of PREM-PS, a patient-reported experience instrument, in a randomized controlled trial of pregnant women undergoing prenatal screening.

Journal of patient-reported outcomes·2026

ETV6, a tumor suppressor gene, is frequently deleted in childhood acute lymphoblastic leukemia (ALL). This study identified ETV6-regulated genes, revealing its crucial role in leukemia development and progression.

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • Deletions in chromosome 12p12-13 are common in childhood acute lymphoblastic leukemia (ALL), implicating a tumor suppressor gene (TSG).
  • ETV6 is strongly implicated as the TSG targeted by these deletions.
  • ETV6's function and targets in leukemia remain incompletely understood.

Purpose of the Study:

  • To identify genes directly or indirectly regulated by ETV6.
  • To investigate the functional impact of ETV6 loss in pre-B acute lymphoblastic leukemia.
  • To determine the correlation between ETV6 expression and candidate target genes in patient samples.

Main Methods:

  • Induction of ETV6 expression in a cellular model.
  • Global gene expression profiling at multiple time points post-induction.

Related Experiment Videos

  • Validation of candidate genes using real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR).
  • Analysis of ETV6 and candidate gene expression in pre-B ALL patient samples.

    • Main Results:

    • Identified 87 genes modulated by ETV6 expression.
    • Validated 10 candidate genes, including IL18, LUM, PTGER4, SPHK1, and TP53.
    • Observed significant correlations between ETV6 expression and IL18, LUM, PTGER4, SPHK1, and TP53 in pre-B ALL patients.

    Conclusions:

    • ETV6 likely regulates the expression of specific genes (IL18, LUM, PTGER4, SPHK1, TP53) in the context of leukemia.
    • This study advances the understanding of ETV6's tumor suppressor functions.
    • The findings highlight the significance of ETV6 inactivation in childhood leukemia pathogenesis.